Alnylam Pharmaceuticals, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2009 | $-1.14 | $-1.67 |
| FY2010 | $-1.04 | $-1.58 |
| FY2011 | $-1.36 | $-1.69 |
| FY2012 | $-2.11 | $-1.99 |
| FY2013 | $-1.45 | $-1.98 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2009 | $-1.14 | $-1.67 |
| FY2010 | $-1.04 | $-1.58 |
| FY2011 | $-1.36 | $-1.69 |
| FY2012 | $-2.11 | $-1.99 |
| FY2013 | $-1.45 | $-1.98 |